11 results
Rhabdomyolysis - Differential Diagnosis and Management Summary

Trauma:
 • Immobilization, Crush iniury, Compartment syndrome, Electrical injury
Exertional:
 •
Drugs (Statins), ... Dermatomyositis) AKI - Pathophysiology ... hour with goal urine ... Management #Summary #causes ... #treatment
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... : 33% • Treatment ... hematology #diagnosis #comparison ... #table
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... accumulation of clinical ... immune deficiency, Drugs ... , Unknown cause ... of emergency, ICU
Cold Urticaria
Prevalence - 0.05% in the population
Disease onset - Mostly 2nd to 4th decades of life
Causes
decades of life Causes ... and clinical associations ... Drugs 5. ... #rheumatology #comparison ... #table
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Discontinuation of causal ... 40, F:M 9:1 • Clinical ... druginduced #lupus #sle #comparison ... #table #rheumatology
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Management Summary Causes ... - Toxins - Drugs ... Dermatomyositis Clinical ... Weakness - Dark urine ... hour with goal urine
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
excretion (e.g., urine ... circulation If drugs ... before beginning treatment ... • Type B1: - Diabetes ... Alcohol • Type B2: Drugs
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
status and low urine ... the determined cause ... #table #foamed ... #criticalcare #icu ... #clinical #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Dosing: 250 mcg tablet ... recommendations for the treatment ... won’t have any clinical ... #Indications #Pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... • Therapeutic drug ... tolerable • Limited clinical ... #antifungals #comparison ... #table #pharmacology